JP2018529625A5 - - Google Patents

Download PDF

Info

Publication number
JP2018529625A5
JP2018529625A5 JP2017551585A JP2017551585A JP2018529625A5 JP 2018529625 A5 JP2018529625 A5 JP 2018529625A5 JP 2017551585 A JP2017551585 A JP 2017551585A JP 2017551585 A JP2017551585 A JP 2017551585A JP 2018529625 A5 JP2018529625 A5 JP 2018529625A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
peptide
seq
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017551585A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018529625A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/052131 external-priority patent/WO2017049082A2/en
Publication of JP2018529625A publication Critical patent/JP2018529625A/ja
Publication of JP2018529625A5 publication Critical patent/JP2018529625A5/ja
Pending legal-status Critical Current

Links

JP2017551585A 2015-09-17 2016-09-16 妊娠特異的糖タンパク質を含む組成物及びその使用方法 Pending JP2018529625A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562219900P 2015-09-17 2015-09-17
US62/219,900 2015-09-17
PCT/US2016/052131 WO2017049082A2 (en) 2015-09-17 2016-09-16 Compositions comprising pregnancy specific glycoproteins and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2018529625A JP2018529625A (ja) 2018-10-11
JP2018529625A5 true JP2018529625A5 (enExample) 2019-10-17

Family

ID=58289625

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017551585A Pending JP2018529625A (ja) 2015-09-17 2016-09-16 妊娠特異的糖タンパク質を含む組成物及びその使用方法

Country Status (6)

Country Link
US (2) USRE50535E1 (enExample)
EP (1) EP3261722B1 (enExample)
JP (1) JP2018529625A (enExample)
AU (1) AU2016323769B2 (enExample)
CA (1) CA2981191C (enExample)
WO (1) WO2017049082A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024514194A (ja) 2021-04-14 2024-03-28 ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド,コーク 変形性関節症の治療に使用するためのpsg1
AU2022259536A1 (en) 2021-04-14 2023-11-09 University College Cork - National University Of Ireland, Cork Treatment of cerebrovascular events and neurological disorders
CN120379687A (zh) 2022-10-14 2025-07-25 爱尔兰国立科克大学 胎盘表达的蛋白用于治疗肌腱损伤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
EP0154316B1 (en) 1984-03-06 1989-09-13 Takeda Chemical Industries, Ltd. Chemically modified lymphokine and production thereof
JP2989002B2 (ja) 1988-12-22 1999-12-13 キリン―アムジエン・インコーポレーテツド 化学修飾顆粒球コロニー刺激因子
US5169835A (en) 1989-01-18 1992-12-08 Oklahoma Medical Research Foundation Pregancy specific proteins applications
US5252714A (en) 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
JP2006503110A (ja) * 2002-10-09 2006-01-26 トーラーレックス, インク. エフェクタt細胞または制御性t細胞に選択的に結合する分子およびその使用方法
CA2772204A1 (en) 2009-08-31 2011-03-03 Amplimmune, Inc. Methods and compositions for the inhibition of transplant rejection

Similar Documents

Publication Publication Date Title
JP2017048194A5 (enExample)
JP2016521688A5 (enExample)
JP2016222689A5 (ja) 合成ペプチド及び乾燥粉末薬剤輸送システム
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
JP2018511327A5 (enExample)
JP2020023567A5 (enExample)
JP2016529229A5 (enExample)
JP2012115277A5 (enExample)
JP2018520997A5 (enExample)
JP2012126742A5 (enExample)
JPWO2019107530A5 (enExample)
MX388822B (es) Composiciones que comprenden peptido wkdeagkplvk.
CN110799522A (zh) 用于治疗、改善或预防脑出血的肽及其用途
JP2015510393A5 (enExample)
JP2016539946A5 (enExample)
EP3936141A3 (en) Anti-senescence compounds and uses thereof
JPWO2019156137A5 (enExample)
JP2017523985A5 (enExample)
RU2017114673A (ru) Слитый белок, наночастица, состоящая из множества мономеров указанного слитого белка, и их применение
HRP20201081T1 (hr) Inhibitorni peptidi porijeklom od trem-sličnog transkripta 1 (tlt-1) i njihove uporabe
JP2019513752A5 (enExample)
JP2006506942A5 (enExample)
JP2014529399A5 (enExample)
JP2015533791A5 (enExample)
JP2017503014A5 (enExample)